Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-056331
Filing Date
2025-12-10
Accepted
2025-12-10 16:35:41
Documents
1
Period of Report
2025-12-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1765402538.html 4  
1 FORM 4 wk-form4_1765402538.xml 4 3995
  Complete submission text file 0001628280-25-056331.txt   5506
Mailing Address 300 FIFTH AVENUE WALTHAM MA 02451
Business Address 300 FIFTH AVENUE WALTHAM MA 02451 617-430-5595
CRESCENT BIOPHARMA, INC. (Issuer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ZELTIQ AESTHETICS INC. 4698 WILLOW ROAD SUITE 100 PLEASANTON CA 94588
Business Address
Brumm Joshua T (Reporting) CIK: 0001528826 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36177 | Film No.: 251562426